Agere CEO to Present at Catalent Applied Drug Delivery Institute Event

Event Assembles World-Class Experts Focused on Overcoming Bioavailability Challenges

Overcoming Bioavailability Challenges Symposium 2014

BEND, Ore.--()--Agere Pharmaceuticals, Inc., a leading innovator in oral bioavailability solutions and specializing in amorphous solid dispersions, announced today that it will present at the Catalent educational symposium this month at the Novartis Basel Campus in Switzerland. The agenda features other renowned experts including those from the Saarland University, 3M, BASF, Catalent Pharma Solutions, Hovione and Formac Pharmaceuticals. Presenters will share insights and offer solutions for current bioavailability challenges.

CONFERENCE: Overcoming Bioavailability Challenges Symposium

When: Thursday, March 27th, 2014 (8:30 AM - 4:30 PM)

Where: Novartis Basel Campus, Switzerland

Agenda & Free Registration: Please follow the link to the event page (

For more information, please contact Agere at

About Agere

Agere is a leading CDMO focused on improving the oral bioavailability of insoluble active pharmaceutical ingredients (APIs). The company supports clients from screening to identify the optimal solubilization technology, through formulation design and development into cGMP manufacturing for Phase I, Phase II and Phase IIb clinical trials. All services follow QbD guidelines, and are delivered on a fee-for-service basis. Agere’s proprietary formulation design platform, Quadrant 2™, enables the company to deliver a customized solution for every compound to serve each individual client’s requirements. The company is located in Bend, OR. For information:

About Catalent Applied Drug Delivery Institute

Catalent’s Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments and foster industry collaboration on major issues pertaining to drug development, formulation and delivery. It is pursuing a multi-tiered approach of research, strategic counsel, and educational programs to advance the adoption of emerging technologies.

For more details, visit

Agere Pharmaceuticals and Quadrant 2 are trademarks owned by Agere Pharmaceuticals, Inc.


Agere Pharmaceuticals, Inc.
Casey Jones, 702-994-0605

Release Summary

Bioavailability formulation expert Agere to present at Catalent Applied Drug Delivery Institute event. Spray drying to create amorphous solid dispersions and overcome poor solubility to be discussed.


Agere Pharmaceuticals, Inc.
Casey Jones, 702-994-0605